Ignoring the window-dressing spike on 3/31, this sustained increase signals that the offloading of bank reserves from big banks to government money market funds has finally started.
This is a short-term relief valve for their balance sheet pressure.
Last time this happened, QE stopped 10 months after (Oct 2014)
This time, Fed may need to continue on at least with some twisting (buying 10Y-30Y bonds, while selling Tbills) for yield control purposes, as net interest expense would skyrocket otherwise.
Pressure on bank's balance sheet is likely to continue on at least into 2022.
due to the overwhelming interest on this, let me expand these data in a couple of blog articles on fed.tips in the next couple of days.
in terms of the implications for
SICO
Fed reaction function
inflation etc.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
The biggest flaw here is that if one follows the conservative approach evident in claiming all experimental antivirals are ineffective, tylenol (paracetamol) would be equally counter-productive, since it depletes glutathione
Glutathione is need in lung for uninfected cells to survive oxidative stress induced by hyperactive immune response, and for sputum clearance
NAC is essential for glutathione synthesis.
Recently a surgical technician died of suspected tylenol overdose after taking the 2nd dose of covid vaccines.
The risk of an acute covid patient overdosing on tylenol should not be neglected
Also discussed is the latest bank B/S outlook including data from MS this morning.
It's a very long update for a slow week, and thus the delay.
Now that I am back in town with a lot more data, time to finish up the SICO series and review what happened in Feb/March. Stay tuned for many articles to be released this weekend on fed.tips.
Done catching up on the data after the trip. Some data dump tonight and tomorrow.
First up, from the Q1 earning data of US GSIBs, they are running closer to SLR limit than they admit, but they are still room in their balance sheet. So they will extend cheap leverage for fees.
And freak out later (2H of Q2)..
GS for example will prefer debt underwriting (leveraged finance) with a 60+% ROE to reserves with 2% ROE at best (20x 10bps IOR).
But we are at the beginning of a new quarter, so they will make money first (extending leverage), and worry about the balance sheet later.
1/ Stimulus Indigestion & Crowding-out: 1. Big picture
This is the total balance sheet size of bankcos in the US.
The big jump in March 2020 ($18Tn to $19.5Tn) forced Fed to suspend SLR. corporate bonds among other things were at risk to be crowded out, if no action were taken
2/ Now we are at $21Tn on 3/10/2021 (pre-stimulus check), this year we would have the following to be added to banks' balance sheet 1. $1Tn TGA balance 2. $3Tn deficit (pre-infrastructure bill) 3. $1Tn from infrastructure bill
Banks need to raise $250Bn to accommodate that.
3/ Context: 2019 they did about $125Bn buyback.
Now they need to raise 2x of that. so understandably, they are not happy.
Just had a crazy week for Fed Balance sheet and TGA
All numbers in $MM.
Looks like we had $109Bn QE in the past week. (yields down, good for the market)
But the $300Bn stimulus is causing short-term indigestion issues soon
(-ve = QE/spending, +ve = QT/tax)
The indigestion problem seemed to have developed at the end of Feb, when QT + deficit spending became very toxic.
QE + deficit spending seemed to be okay.
Had to spend some time to investigate some highly unusual activity, where a whale pulled $200Bn liquidity in short order, and then puked it back between 2/17 and 3/2.
Will finish up writing up the projection for the next two weeks today and launch the newsletter today.